Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:VBIV

VBI Vaccines (VBIV) Stock Price, News & Analysis

VBI Vaccines logo

About VBI Vaccines Stock (NASDAQ:VBIV)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$0.02
$0.79
52-Week Range
N/A
Volume
29.90 million shs
Average Volume
3.66 million shs
Market Capitalization
$1.87 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive VBIV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for VBI Vaccines and its competitors with MarketBeat's FREE daily newsletter.

VBIV Stock News Headlines

Banks aren’t ready for this altcoin—are you?
I've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. This is about being in the right place at the right time – and I believe that time is now.
Why Is VBI Vaccines (VBIV) Stock Up 62% Today?
See More Headlines

VBIV Stock Analysis - Frequently Asked Questions

VBI Vaccines Inc. (NASDAQ:VBIV) issued its earnings results on Monday, March, 13th. The biopharmaceutical company reported ($1.60) earnings per share for the quarter, missing analysts' consensus estimates of ($1.40) by $0.20. The biopharmaceutical company earned $0.29 million during the quarter, compared to analysts' expectations of $1.98 million. VBI Vaccines had a negative trailing twelve-month return on equity of 525.42% and a negative net margin of 881.79%.

VBI Vaccines's stock reverse split on Wednesday, April 12th 2023.The 1-20 reverse split was announced on Wednesday, April 12th 2023. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, April 12th 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that VBI Vaccines investors own include Inovio Pharmaceuticals (INO), Vaxart (VXRT), NVIDIA (NVDA), Sorrento Therapeutics (SRNE), Advanced Micro Devices (AMD), Pfizer (PFE) and Novavax (NVAX).

Company Calendar

Last Earnings
3/13/2023
Today
7/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:VBIV
Fax
N/A
Employees
22
Year Founded
2001

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$92.84 million
Net Margins
-881.79%
Pretax Margin
-881.79%

Debt

Sales & Book Value

Annual Sales
$9.41 million
Price / Cash Flow
N/A
Book Value
$0.32 per share
Price / Book
N/A

Miscellaneous

Free Float
25,713,000
Market Cap
$1.87 million
Optionable
Optionable
Beta
2.18

Social Links

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (NASDAQ:VBIV) was last updated on 7/7/2025 by MarketBeat.com Staff
From Our Partners